ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious

Sanjeeve Balasubramaniam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.